BENEPALI®, the First Etanercept Biosimilar Referencing Enbrel®, Approved in …

BENEPALI®, the First Etanercept Biosimilar Referencing Enbrel®, Approved in …

BENEPALI has been granted marketing authorization in the European Union (EU) for the treatment of adults with moderate to severe rheumatoid arthritis (RA), psoriatic arthritis, non-radiographic axial spondyloarthritis and plaque psoriasis. Biogen

(Visited 4 times, 1 visits today)
5
Like
Save

Comments

Comments are disabled for this post.